- Who We Are
- Who We Serve
- Our Tissues & Products
- Contact Us
January 8, 2015 — The Musculoskeletal Transplant Foundation (MTF) Wound Care division announced today that it has signed a group purchasing agreement with Premier, Inc., a leading healthcare improvement company. The agreement offers Premier alliance members access to MTF Wound Care’s innovative line of biologic tissue forms.
MTF Wound Care will initially offer Premier alliance members access to two tissue forms: AmnioBandTM Membrane, a human derived allograft placental matrix and AlloPatchTM Pliable, a human derived allograft dermal matrix.
“This is an exciting extension of our existing Premier partnership,” said Kim Rounds, Vice President of MTF Wound Care. “We can now bring innovative and healing wound care solutions to Premier’s patients and surgeons—many of whom already choose a broad selection of MTF tissues for their patients.”
According to the National Institute of Health (NIH), treating chronic wounds is a growing concern, fueled by increasing costs, an aging population and a sharp rise in such conditions as obesity and diabetes. NIH reports that in the United States alone, more than $25 billion is spent annually to treat chronic wounds.
Given the mounting need, MTF Wound Care is dedicated to developing highly advanced, safe, clinically based and cost-effective wound care solutions that work in concert with the body’s natural healing process.
MTF Wound Care is a division of MTF, the nation’s leading tissue bank. MTF supplies specialty donated human tissue for use by surgeons in orthopedic, spine, plastic and general surgery and sports medicine procedures. Founded by surgeons over 25 years ago, MTF maintains strict standards for donor recovery criteria and tissue processing. With over 100,000 donors recovered and over six million grafts distributed since its founding, MTF has maintained an exemplary reputation for safety and quality.